BMJ – Evusheld: Government is urged to expedite covid antibody treatment for vulnerable patients
October 2022
Pink Sheet – Evusheld: UK urged to use RWD to give clinically vulnerable early access to COVID-19 treatment
September 2022
European Pharmaceutical Review – How can evidence-based medicine (EBM) methodology support drug withdrawals
July 2022
Pharmafocus – Key trends for UK drug safety in 2022
January 2022
News Medical – Heart inflammation more common among men following mRNA-based COVID-19 vaccination
September 2021
EPM magazine – The MedTalk Podcast – Understanding Covid-19 vaccines with the DSRU
August 2021
EPM magazine – Flu vaccine monitoring in the UK to include teenagers for the first time
August 2021
Pharma Jobs – DSRU says more research needed to understand immunocompromised patients’ responses to Covid-19 vaccines
July 2021
Pharmatimes – DSRU says more research needed to understand immunocompromised patients’ responses to Covid-19 vaccines
July 2021
Pink Sheet: Vaccine study kicks off in the UK (2/7/21 Covid notebook – subscription required)
July 2021
Guardian: Windmills of your mind: viral Covid jab ‘hack’ placebo effect at best, say doctors
June 2021
PharmaTimes – Safety first
May 2021
Guardian – Keep taking AstraZeneca jab, says PM, as trial paused to investigate clot reports (7/4/21 p6/7)
April 2021
Scrip – Regulators reassure on AZ vaccine safety after rare side effects deemed plausible
April 2021
Financial Review – European, UK experts turn up pressure on AstraZeneca over blood clots
April 2021
Nature – Covid vaccines and blood clots: Five key questions
April 2021
European Pharmaceutical Review – US pauses administration of Janssen Covid-19 vaccine
April 2021
Pharmacy Business – Pharmacists urged to promote Oxford vaccine safety study among patients
April 2021
European Pharmaceutical Review – Global pharmacovigilance observatory to aid pharma’s understanding of regulatory decisions
April 2021
PharmaTimes – Benefits of AZ vaccine outweigh risks, say MHRA
April 2021
Guardian – AstraZeneca jab worry may play into the hands of anti-vaxxers, say Tories Also covered by Yahoo and MSN
April 2021
Guardian – Wednesday briefing: Keep getting jab, Johnson urges
April 2021
MSN – Oxford/AstraZeneca jab could have causal link to rare blood clots, say UK experts
April 2021
Guardian – Oxford/AstraZeneca jab could have causal link to rare blood clots, say UK experts
April 2021
FT – Blood clots and the AstraZeneca Covid vaccine:
April 2021
Pharmacy Business – Pharmacists urged to promote Oxford vaccine safety study among patients
April 2021
Daily Mail – Why are drugs for the old tested on the young?
March 2021
European Pharmaceutical Manufacturer – Oxford/AstraZeneca Covid-19 vaccine should continue to be used, UK researchers say
March 2021
Pharmacy Business – Pharmacists urged to participate in Oxford vaccine safety study
March 2021
Guardian – Politics Live blog updating on a range of Covid-19 developments
March 2021
The BMJ – Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance
March 2021
https://www.dailymail.co.uk/health/article-9339743/Why-drugs-old-tested-young.html
March 2021
European Pharmaceutical Manufacturer – Post market study of Oxford Covid-19 vaccine begins
February 2021
Portsmouth News – Portsmouth associate drug safety unit to study side effects of COVID-19 vaccine
February 2021
Nursing Times – Call for nurses to join Covid-19 vaccine side effects study
February 2021
South Wales Argus – Oxford/AstraZeneca vaccine safety study – Wales recruits needed
February 2021
Southampton Echo – Southampton drug safety unit to start study of COVID-19 vaccine
February 2021
Reuters UK – What you need to know about coronavirus right now
December 2020
Newsbreak.com – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
PharmaTimes – The Covid vaccines safety net
December 2020
County Press (Isle of Wight) – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
The National (Scotland) – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
Thisislocallondon – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
AOL – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
MSN – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
PharmaTimes – DSRU plans post-authorisation study of Covid-19 vaccines in the UK
December 2020
European Pharmaceutical Review – Drug Safety Research Unit says repurposed drugs for Covid-19 still require a lot of testing
November 2020
European Pharmaceutical Manufacturer – Re-purposed drugs for Covid-19 need rigorous testing
November 2020
Pink Sheet (30/11/20) – Coronavirus Notepad: Repurposed drugs need thorough testing (link for subscribers)
November 2020
European Pharmaceutical Manufacturer – UK research unit stresses need for monitoring of newly licensed Covid-19 vaccines
November 2020
Pink Sheet (16/11/20) – EU mandates monthly safety summaries for approved Covid-19 vaccines (DSRU comments on the need for robust post-authorisation safety studies)
November 2020
Pharmafocus – Opportunities and challenges for re-purposing drugs for Covid-19 (p12, Nov edition)
November 2020
Pharmafile – Remdesivir has favourable benefit-risk profile in Covid-19 but more data needed, DSRU review argues
October 2020
Pharmatimes.co.uk – Systematic benefit-risk study deems remdesivir a favourable Covid-19 treatment
October 2020
Pink Sheet – Coronavirus Notebook: Convalescent Plasma – Will It Recover From Setbacks?
September 2020
The Scientist – Scientists voice concerns over Russian COVID-19 vaccine
September 2020
Chemistry World – Russian Covid-19 vaccine data raises questions
September 2020
BMJ – Covid-19: US FDA fires spokesperson over misleading claims about convalescent plasma. Summary of DSRU’s benefit risk research included.
September 2020
European Pharmaceutical Review – COVID-19 vaccines to be monitored post marketing by consortium in the UK
August 2020
European Pharmaceutical Manufacturer – Post-market study to monitor safety and effectiveness of COVID-19 vaccines
August 2020
Pharmafield – One Million study to monitor COVID-19 vaccine safety and effectiveness
August 2020
Pink Sheet – Coronavirus Notebook: Convalescent Plasma – Will It Recover From Setbacks?
August 2020
BMJ – Covid-19: US FDA fires spokesperson over misleading claims about convalescent plasma. Summary of DSRU’s benefit risk research included.
August 2020
Pink Sheet: Coronavirus Notebook – Post Authorization Studies. DSRU’s ‘One Million’ study to monitor COVID-19 vaccines was mentioned in Pink Sheet’s weekly round-up(18/8/20)
August 2020
Pharmafield – No clear benefit of HIV antivirals for COVID-19 patients says study
July 2020
Pink Sheet – Coronavirus Notebook
July 2020
European Pharmaceutical Review – Consortium established to monitor COVID-19 vaccines after marketing
June 2020
PharmaTimes – New consortium will monitor safety/efficacy of COVID-19 vaccines
June 2020
The Courier – Dundee and St Andrews universities spearheading Covid-19 vaccine studies
June 2020
Pharmaceutical Technology – UK researchers form consortium to monitor Covid-19 vaccines
June 2020
European Pharmaceutical Manufacturer – Consortium formed to assess safety of Covid-19 vaccines
June 2020
Pharmafield – New consortium to monitor safety and effectiveness of Covid-19 vaccines
June 2020
Pharmafile – New UK consortium established to monitor COVID-19 vaccine efficacy once they hit market
June 2020
Pink Sheet – New Consortium To Monitor Whether COVID-19 Vaccines Work As They Should
June 2020
PharmaTimes – PharmaTimes talks to Professor Saad Shakir
May 2020
PharmaTimes – Remdesivir for COVID-19 patients is ‘favourable’, study finds
May 2020
Pharmafile Therapeutic Areas in Focus – Direct oral anticoagulants: Examining their use in a real world secondary care setting (Vol 69 Spring 2020, p32-34)
May 2020
European Pharmaceutical Review – Cytokine storms a major killer in patients with severe COVID-19 infection
April 2020
Drug Target Review – Cytokine storms a major killer in patients with severe COVID-19 infection
April 2020
Pharmaceutical Journal – Buprenorphine implant beneficial for patients with opioid dependency
April 2020
Pharmafocus – The need for evolution in pharmacovigilance (p16/17 March 2020 edition)
March 2020
PharmaTimes – BMJ journal deems opioid dependency implant more favourable than tablets
March 2020
PharmaTimes – Improve brand and batch number recording, urge drug safety professionals
January 2020
Pharmafield – Better recording of biologic medicines brand and batch numbers needed for patient safety
January 2020
European Pharmaceutical Magazine – Improvements needed in biologics traceability to ensure patient safety
January 2020
Pharmaceutical Journal – Researchers unable to identify batches of biologic drugs from 85% of Yellow Card report
January 2020
PharmaTimes – Is the UK facing its own opioid crisis?
November 2019
The BMJ – GPs are urged to help monitor new drugs
October 2019
Daily Mail – ‘Last resort’ pill that brings nightmares (p.5 August print edition)
August 2019
LBC Radio – DSRU Director, Saad Shakir, interviewed for LBC Radio about the adverse side effects of anti-malaria drug, Mefloquine, in relation to the death of student Alana Cutland
August 2019
European Pharmaceutical Manufacturer Magazine – Use of real world data important for improving medicine safety
July 2019
OnMedica – Treatment for hyperthyroidism linked to increased risk of cancer death
July 2019
Daily Mail – Taking heartburn pills ‘DOUBLES your risk of developing an allergy because suppressing stomach acid destroys the body’s defense barrier’
July 2019
Pharma Times – Big Pharma, come back to mental health and invest in Europe
May 2019
Pharma Times – Big Pharma come together for better drug side effect detection
April 2019
Pink Sheet – New international signal detection initiative to influence industry practice
April 2019
Pharmaceutical Journal – Pharmaceutical companies vow to improve monitoring of medicine side effects
April 2019